Pure Biologics Spólka Akcyjna (PUR) — Financial Flexibility Index
Pure Biologics Spólka Akcyjna (PUR) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of zł-216.00K (operating CF zł-216.00K minus capex zł0.00) represents 0% of total liabilities (zł20.72 Million). Check Pure Biologics Spólka Akcyjna investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pure Biologics Spólka Akcyjna Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Pure Biologics Spólka Akcyjna across 9 annual periods. For the full cash flow conversion analysis, see Pure Biologics Spólka Akcyjna cash conversion from operations.
Annual Financial Flexibility Index for Pure Biologics Spólka Akcyjna (2016–2024)
Year-by-year free cash flow to debt coverage for Pure Biologics Spólka Akcyjna. Explore PUR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.70x | zł-10.83 Million | zł-10.83 Million | zł15.46 Million | ▲ +36.8% |
| 2023 | -1.11x | zł-23.09 Million | zł-23.26 Million | zł20.84 Million | ▼ -40.1% |
| 2022 | -0.79x | zł-11.63 Million | zł-17.39 Million | zł14.71 Million | ▲ +73.9% |
| 2021 | -3.03x | zł-23.36 Million | zł-24.04 Million | zł7.70 Million | ▼ -8258.0% |
| 2020 | -0.04x | zł-792.00K | zł-1.35 Million | zł21.83 Million | ▼ -109.6% |
| 2019 | 0.38x | zł5.50 Million | zł5.33 Million | zł14.57 Million | ▲ +170.7% |
| 2018 | -0.53x | zł-2.33 Million | zł-2.49 Million | zł4.36 Million | ▲ +77.8% |
| 2017 | -2.41x | zł-2.69 Million | zł-2.85 Million | zł1.12 Million | ▼ -473.2% |
| 2016 | -0.42x | zł-268.74K | zł-710.24K | zł640.12K | — |